{"id":"moclobemide","rwe":[],"tags":[{"label":"Monoamine Oxidase Inhibitors","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Amine oxidase [flavin-containing] A","category":"target"},{"label":"MAOA","category":"gene"},{"label":"MAOB","category":"gene"},{"label":"HTR1A","category":"gene"},{"label":"N06AG02","category":"atc"},{"label":"Active","category":"status"},{"label":"Depressive disorder","category":"indication"},{"label":"Antidepressive Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Monoamine Oxidase Inhibitors","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":349.506,"date":"","count":101,"signal":"Serotonin syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 101 times (LLR=350)"},{"llr":194.817,"date":"","count":82,"signal":"Intentional overdose","source":"DrugCentral FAERS","actionTaken":"Reported 82 times (LLR=195)"},{"llr":152.858,"date":"","count":30,"signal":"Physical deconditioning","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=153)"},{"llr":109.393,"date":"","count":90,"signal":"Drug interaction","source":"DrugCentral FAERS","actionTaken":"Reported 90 times (LLR=109)"},{"llr":94.735,"date":"","count":47,"signal":"Suicide attempt","source":"DrugCentral FAERS","actionTaken":"Reported 47 times (LLR=95)"},{"llr":94.564,"date":"","count":27,"signal":"Major depression","source":"DrugCentral FAERS","actionTaken":"Reported 27 times (LLR=95)"},{"llr":63.433,"date":"","count":12,"signal":"Dissociative disorder","source":"DrugCentral FAERS","actionTaken":"Reported 12 times (LLR=63)"},{"llr":62.966,"date":"","count":36,"signal":"Suicidal ideation","source":"DrugCentral FAERS","actionTaken":"Reported 36 times (LLR=63)"},{"llr":59.622,"date":"","count":29,"signal":"Depressed mood","source":"DrugCentral FAERS","actionTaken":"Reported 29 times (LLR=60)"},{"llr":59.517,"date":"","count":33,"signal":"Metabolic acidosis","source":"DrugCentral FAERS","actionTaken":"Reported 33 times (LLR=60)"},{"llr":56.948,"date":"","count":63,"signal":"Toxicity to various agents","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=57)"},{"llr":48.328,"date":"","count":10,"signal":"Apallic syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=48)"},{"llr":47.148,"date":"","count":30,"signal":"Electrocardiogram QT prolonged","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=47)"},{"llr":46.252,"date":"","count":8,"signal":"Serum serotonin increased","source":"DrugCentral FAERS","actionTaken":"Reported 8 times (LLR=46)"},{"llr":46.112,"date":"","count":25,"signal":"Disturbance in attention","source":"DrugCentral FAERS","actionTaken":"Reported 25 times (LLR=46)"}],"drugInteractions":[{"url":"/drug/alpha/beta-agonists","drug":"Alpha/Beta Agonists","action":"Use caution","effect":"MAO Inhibitors may enhance the hypertensive effect of Alpha/Beta-Agonists","source":"DrugCentral","drugSlug":"alpha/beta-agonists"},{"url":"/drug/amphetamines","drug":"Amphetamines","action":"Use caution","effect":"MAO Inhibitors may enhance the hypertensive effect of amphetamines","source":"DrugCentral","drugSlug":"amphetamines"},{"url":"/drug/indirectly-acting-sympathomimetic-amines","drug":"Indirectly Acting Sympathomimetic Amines","action":"Contraindicated","effect":"potentially fatal hypertensive crisis","source":"DrugCentral","drugSlug":"indirectly-acting-sympathomimetic-amines"},{"url":"/drug/selective-serotonin-reuptake-inhibitors","drug":"Selective Serotonin Reuptake Inhibitors","action":"Contraindicated","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"selective-serotonin-reuptake-inhibitors"},{"url":"/drug/serotonin/norepinephrine-reuptake-inhibitors","drug":"Serotonin/Norepinephrine Reuptake Inhibitors","action":"Contraindicated","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"serotonin/norepinephrine-reuptake-inhibitors"},{"url":"/drug/tricyclic-antidepressants","drug":"Tricyclic Antidepressants","action":"Contraindicated","effect":"very toxic and sometimes fatal reactions the serotonin syndrome or similar","source":"DrugCentral","drugSlug":"tricyclic-antidepressants"},{"url":"/drug/buspirone","drug":"buspirone","action":"Use caution","effect":"May increase blood pressure","source":"DrugCentral","drugSlug":"buspirone"},{"url":"/drug/dextromethorphan","drug":"dextromethorphan","action":"Contraindicated","effect":"fatal/non-fatal reactions","source":"DrugCentral","drugSlug":"dextromethorphan"},{"url":"/drug/levodopa","drug":"levodopa","action":"Contraindicated","effect":"life-threatening hypertensive reaction","source":"DrugCentral","drugSlug":"levodopa"},{"url":"/drug/methyldopa","drug":"methyldopa","action":"Use caution","effect":"hypertension may occur","source":"DrugCentral","drugSlug":"methyldopa"},{"url":"/drug/mirtazapine","drug":"mirtazapine","action":"Contraindicated","effect":"Label warning","source":"DrugCentral","drugSlug":"mirtazapine"},{"url":"/drug/pethidine","drug":"pethidine","action":"Use caution","effect":"potentially life-threatening reaction","source":"DrugCentral","drugSlug":"pethidine"},{"url":"/drug/phenylephrine","drug":"phenylephrine","action":"Contraindicated","effect":"potentially fatal hypertensive crisis","source":"DrugCentral","drugSlug":"phenylephrine"},{"url":"/drug/tramadol","drug":"tramadol","action":"Use caution","effect":"serotonin syndrome","source":"DrugCentral","drugSlug":"tramadol"},{"url":"/drug/tryptophan","drug":"tryptophan","action":"Contraindicated","effect":"severe behavioural and neurological signs of toxicity","source":"DrugCentral","drugSlug":"tryptophan"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=MOCLOBEMIDE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:02:10.893807+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:02:16.495431+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MOCLOBEMIDE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:02:16.977360+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Monoamine oxidase A inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:18.026213+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL86304/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:17.675066+00:00"}},"allNames":"auromid","offLabel":[],"synonyms":["moclobamide","moclobemide","auromid","aurorix","moclaime"],"timeline":[{"date":"1990-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1990-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Auromid","ecosystem":[{"indication":"Depressive disorder","otherDrugs":[{"name":"amitriptyline","slug":"amitriptyline","company":"Astrazeneca"},{"name":"amoxapine","slug":"amoxapine","company":"Lederle"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"citalopram","slug":"citalopram","company":"Forest Labs"}],"globalPrevalence":280000000}],"mechanism":{"target":"Amine oxidase [flavin-containing] A","targets":[{"gene":"MAOA","source":"DrugCentral","target":"Amine oxidase [flavin-containing] A","protein":"Amine oxidase [flavin-containing] A"},{"gene":"MAOB","source":"DrugCentral","target":"Amine oxidase [flavin-containing] B","protein":"Amine oxidase [flavin-containing] B"},{"gene":"HTR1A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 1A","protein":"5-hydroxytryptamine receptor 1A"},{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"}],"modality":"Small Molecule","drugClass":"Monoamine Oxidase Inhibitors","explanation":"","oneSentence":"","technicalDetail":"Auromid reversibly inhibits monoamine oxidase A (MAO-A), a flavin-containing enzyme responsible for the oxidative deamination of monoamine neurotransmitters, thereby increasing their availability and contributing to its antidepressant effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1825","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=MOCLOBEMIDE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MOCLOBEMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:49:26.881341","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:20.164099+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"abemaciclib","drugSlug":"abemaciclib","fdaApproval":"2017-09-28","patentExpiry":"Sep 28, 2031","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"alosetron","drugSlug":"alosetron","fdaApproval":"2000-02-09","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"amitriptyline","drugSlug":"amitriptyline","fdaApproval":"1961-04-07","genericCount":33,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"amodiaquine","drugSlug":"amodiaquine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"aripiprazole","drugSlug":"aripiprazole","fdaApproval":"2002-11-15","patentExpiry":"Sep 24, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"arsenic trioxide","drugSlug":"arsenic-trioxide","fdaApproval":"2000-09-25","genericCount":11,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"asciminib","drugSlug":"asciminib","fdaApproval":"2021-10-29","patentExpiry":"Oct 29, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-target"},{"drugName":"atomoxetine","drugSlug":"atomoxetine","fdaApproval":"2002-11-26","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-target"}],"genericName":"moclobemide","indications":{"approved":[{"name":"Depressive disorder","source":"DrugCentral","snomedId":35489007,"regulator":"FDA","usPrevalence":21000000,"globalPrevalence":280000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"abemaciclib","brandName":"abemaciclib","genericName":"abemaciclib","approvalYear":"2017","relationship":"same-target"},{"drugId":"alosetron","brandName":"alosetron","genericName":"alosetron","approvalYear":"2000","relationship":"same-target"},{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-target"},{"drugId":"amitriptyline","brandName":"amitriptyline","genericName":"amitriptyline","approvalYear":"1961","relationship":"same-target"},{"drugId":"amodiaquine","brandName":"amodiaquine","genericName":"amodiaquine","approvalYear":"","relationship":"same-target"},{"drugId":"aripiprazole","brandName":"aripiprazole","genericName":"aripiprazole","approvalYear":"2002","relationship":"same-target"},{"drugId":"arsenic-trioxide","brandName":"arsenic trioxide","genericName":"arsenic trioxide","approvalYear":"2000","relationship":"same-target"},{"drugId":"asciminib","brandName":"asciminib","genericName":"asciminib","approvalYear":"2021","relationship":"same-target"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-target"},{"drugId":"atomoxetine","brandName":"atomoxetine","genericName":"atomoxetine","approvalYear":"2002","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT05737511","phase":"PHASE4","title":"Efficacy of Hydroxyzine for Patients With Panic Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2023-12-30","conditions":["Panic Disorder"],"enrollment":80,"completionDate":"2026-12-30"},{"nctId":"NCT01962753","phase":"NA","title":"Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2012-05-10","conditions":["Elderly","Major Depression"],"enrollment":92,"completionDate":"2020-01-22"},{"nctId":"NCT04460274","phase":"","title":"Forecast Number of Covid-19 Cases Worldwide","status":"COMPLETED","sponsor":"Turkish Ministry of Health Izmir Teaching Hospital","startDate":"2019-12-31","conditions":["Covid-19"],"enrollment":7882471,"completionDate":"2020-06-20"},{"nctId":"NCT03010761","phase":"PHASE2","title":"Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer","status":"TERMINATED","sponsor":"China Medical University Hospital","startDate":"2016-01-14","conditions":["Addiction"],"enrollment":90,"completionDate":"2018-01-31"},{"nctId":"NCT02269540","phase":"EARLY_PHASE1","title":"A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2014-10","conditions":["Major Depressive Disorder"],"enrollment":10,"completionDate":"2018-07"},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":["Dementia","Depression","Schizophrenia","Psychosomatic Disorders","Anxiety Disorders"],"enrollment":407,"completionDate":"2017-06-28"},{"nctId":"NCT01926626","phase":"PHASE2","title":"Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers","status":"COMPLETED","sponsor":"Jed E. Rose","startDate":"2013-09","conditions":["Nicotine Dependence"],"enrollment":76,"completionDate":"2014-10"},{"nctId":"NCT00534573","phase":"PHASE3","title":"Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation","status":"COMPLETED","sponsor":"Beersheva Mental Health Center","startDate":"2008-11","conditions":["Clozapine-induced Hypersalivation"],"enrollment":54,"completionDate":"2009-01"},{"nctId":"NCT00704860","phase":"PHASE4","title":"Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism","status":"COMPLETED","sponsor":"University of Ottawa","startDate":"2005-02","conditions":["Major Depression"],"enrollment":27,"completionDate":"2010-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000166883","NDDF":"004179","UNII":"PJ0Y7AZB63","CHEBI":"CHEBI:83531","INN_ID":"4914","RXNORM":"30121","UMLSCUI":"C0066673","chemblId":"CHEMBL86304","ChEMBL_ID":"CHEMBL86304","KEGG_DRUG":"D02561","DRUGBANK_ID":"DB01171","PUBCHEM_CID":"4235","SNOMEDCT_US":"321911007","IUPHAR_LIGAND_ID":"7428","MESH_DESCRIPTOR_UI":"D020912"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.5 hours","clearance":"10.0 mL/min/kg","bioavailability":"75%","fractionUnbound":"0.77%","volumeOfDistribution":"1.1 L/kg"},"publicationCount":1015,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N06AG02","allCodes":["N06AG02"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1990","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1990-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:20.164099+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}